Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cartesian Therapeutics (RNAC) Exchange Rate Effect: 2015-2025

Historic Exchange Rate Effect for Cartesian Therapeutics (RNAC) over the last 10 years, with Sep 2025 value amounting to -$10,000.

  • Cartesian Therapeutics' Exchange Rate Effect rose 33.33% to -$10,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $19,000, marking a year-over-year increase of 90.00%. This contributed to the annual value of -$21,000 for FY2024, which is 60.38% up from last year.
  • Per Cartesian Therapeutics' latest filing, its Exchange Rate Effect stood at -$10,000 for Q3 2025, which was down 183.33% from $12,000 recorded in Q2 2025.
  • Cartesian Therapeutics' Exchange Rate Effect's 5-year high stood at $115,000 during Q2 2022, with a 5-year trough of -$45,000 in Q4 2022.
  • Over the past 3 years, Cartesian Therapeutics' median Exchange Rate Effect value was -$10,000 (recorded in 2025), while the average stood at -$3,636.
  • Its Exchange Rate Effect has fluctuated over the past 5 years, first slumped by 650.00% in 2022, then skyrocketed by 740.00% in 2025.
  • Quarterly analysis of 5 years shows Cartesian Therapeutics' Exchange Rate Effect stood at -$6,000 in 2021, then crashed by 650.00% to -$45,000 in 2022, then spiked by 135.56% to $16,000 in 2023, then crashed by 193.75% to -$15,000 in 2024, then surged by 33.33% to -$10,000 in 2025.
  • Its last three reported values are -$10,000 in Q3 2025, $12,000 for Q2 2025, and $32,000 during Q1 2025.